CompoAtlas

JAMPZINC-HC

Natural health product licensed in Canada

Licence holder
JAMP Pharma Corporation
NPN or DIN-HM
80056810
Status
Active licence
Licence date
25 December 2014
Revision date
Not provided
Form
Onguent
Route of administration
Topique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Prégn-4-ène-3,20-dione, 21-(acétyloxy)-11,17-dihydroxy-, (11bêta)-

Source : Acétate d'hydrocortisone

0.5 %

Non-medicinal ingredients

(p)-hydroxybenzoate de méthyle, Diazolidinyl urée, Pétrolatum blanc, Huile minérale légère, (p)-hydroxybenzoate de propyle

PopulationAgeQuantity per servingFrequency
Adultes et enfantsminimum: 2 yearsNot specifiedminimum: 2 Tous les jours ; maximum: 4 Tous les jours
Adultes et enfantsminimum: 12 yearsNot specifiedminimum: 3 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

For temporary relief of minor skin irritations associated with redness, itching, dryness and scaling; minor skin irritations, rashes, itching and redness due to eczema, insect bites, poison ivy, poison oak, poison sumac, contact dermatitis (e.g. caused by soaps, detergents, cosmetics and/or jewellery), seborrheic dermatitis, psoriasis. For temporary relief of external genital, feminine or anal itching (due to hemorrhoids). Anti-pruritic. Anti-itch.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80056810

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line